A. Boucenna, A. Hirech, R. M. Larbi, and D. Satta, “Impact of CYP2D6 Polymorphisms in Predicting Occurrence of Adverse Effect to Tamoxifen and Developing Recurrence in ER+ Breast Cancer Patients”, Arch Breast Cancer, vol. 11, no. 4, Oct. 2024.